Anterior uveitis after treatment of age-related macular degeneration with ranibizumab and bevacizumab: Uncommon complication

11Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

The authors describe one case of anterior uveitis after treatment of age-related macular degeneration with both antiangiogenic drugs: ranibizumab and bevacizumab. The case is described as a complication of ranibizumab and bevacizumab due to an inflammatory process. Several reasons are suggested to explain this possibility, and the authors conclude that the main cause remains unknown. © 2012 Damasceno et al, publisher and licensee Dove Medical Press Ltd.

Cite

CITATION STYLE

APA

Damasceno, N., Horowitz, S., & Damasceno, E. (2012). Anterior uveitis after treatment of age-related macular degeneration with ranibizumab and bevacizumab: Uncommon complication. Clinical Ophthalmology, 6(1), 1201–1205. https://doi.org/10.2147/OPTH.S31239

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free